Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Ampicillin,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Avenacy Announces Launch of Five Injectable Antibiotic Products in the U.S. Market
Details : Avenacy has launched a suite of antibiotic products for injection, including ampicillin, ampicillin and sulbactam, nafcillin, piperacillin and tazobactam.
Product Name : Omnipen-N-Generic
Product Type : Antibiotic
Upfront Cash : Inapplicable
March 17, 2025
Lead Product(s) : Ampicillin,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ampicillin,Gentamicin Sulfate
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase III
Sponsor : The University of Pittsburgh School of Medicine | Morgan Stanley Children’s Hospital | University of Louisville | Sharp Mary Birch Hospital for Women & Newborns | Children's Hospital of Philadelphia | Jefferson Medical College of Thomas Jefferson Universi
Deal Size : Inapplicable
Deal Type : Inapplicable
NICU Antibiotics and Outcomes (NANO) Follow-up Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
August 04, 2023
Lead Product(s) : Ampicillin,Gentamicin Sulfate
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase III
Sponsor : The University of Pittsburgh School of Medicine | Morgan Stanley Children’s Hospital | University of Louisville | Sharp Mary Birch Hospital for Women & Newborns | Children's Hospital of Philadelphia | Jefferson Medical College of Thomas Jefferson Universi
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Rosuvastatin Calcium,Ampicillin
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 15, 2019
Lead Product(s) : Rosuvastatin Calcium,Ampicillin
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Cefazolin,Gentamicin Sulfate,Ceftriaxone,Ampicillin,Sulbactam,Piperacillin Sodium,Tazobactam Sodium
Therapeutic Area : Orthopedics/Orthopedic Surgery
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Noninferiority Comparison of Prophylactic Open Fracture Antimicrobial Regimens
Details : Undisclosed
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
June 18, 2018
Lead Product(s) : Cefazolin,Gentamicin Sulfate,Ceftriaxone,Ampicillin,Sulbactam,Piperacillin Sodium,Tazobactam Sodium
Therapeutic Area : Orthopedics/Orthopedic Surgery
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Cephalosporin,Levofloxacin,Clindamycin Hydrochloride,Ampicillin,Gentamicin Sulfate
Therapeutic Area : Nephrology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Trial of Randomized Antibiotic Administration in Percutaneous Nephrolithotomy
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
October 19, 2015
Lead Product(s) : Cephalosporin,Levofloxacin,Clindamycin Hydrochloride,Ampicillin,Gentamicin Sulfate
Therapeutic Area : Nephrology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ceftaroline Fosamil,Ampicillin,Aminoglycoside
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : PRA Health Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety, Tolerability and Efficacy of Ceftaroline in Paediatrics With Late-Onset Sepsis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 23, 2015
Lead Product(s) : Ceftaroline Fosamil,Ampicillin,Aminoglycoside
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : PRA Health Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ampicillin,Metronidazole,Gentamicin Sulfate,Clindamycin Hydrochloride,Piperacillin Sodium,Tazobactam Sodium
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II/ Phase III
Sponsor : The Emmes Company, LLC
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
November 26, 2013
Lead Product(s) : Ampicillin,Metronidazole,Gentamicin Sulfate,Clindamycin Hydrochloride,Piperacillin Sodium,Tazobactam Sodium
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II/ Phase III
Sponsor : The Emmes Company, LLC
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ampicillin,Inapplicable
Therapeutic Area : Genetic Disease
Study Phase : Phase I
Sponsor : Tyler's Hope for a Dystonia Cure, Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Ampicillin for DYT-1 Dystonia Motor Symptoms
Details : Undisclosed
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
September 14, 2011
Lead Product(s) : Ampicillin,Inapplicable
Therapeutic Area : Genetic Disease
Highest Development Status : Phase I
Sponsor : Tyler's Hope for a Dystonia Cure, Inc
Deal Size : Inapplicable
Deal Type : Inapplicable